ConductScience.org, home

Paper40896702

Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease.

Ghasemzadeh Rahbardar M and 1 other. Iran J Basic Med Sci, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease. Papers, record 40896702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40896702

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease.
PubMed
Journal
Iran J Basic Med Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-09-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ghasemzadeh Rahbardar MMahboobeh
2Sahebkar AAmirhossein

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References149

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124629563Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation.Metabolism2014https://conductscience.org/library/papers/24629563PubMed
234052324Resveratrol for cancer therapy: Challenges and future perspectives.Cancer Lett2021https://conductscience.org/library/papers/34052324PubMed
333181351The NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer's disease.Curr Opin Immunol2021https://conductscience.org/library/papers/33181351PubMed
436444628The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease.Immun Inflamm Dis2022https://conductscience.org/library/papers/36444628PubMed
532047476The Inflammasome in Reproductive Biology: A Promising Target for Novel Therapies.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/32047476PubMed
625642707Evasion of inflammasome activation by microbial pathogens.J Clin Invest2015https://conductscience.org/library/papers/25642707PubMed
737564636Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage.Front Immunol2023https://conductscience.org/library/papers/37564636PubMed
821889967Autoimmune and inflammatory mechanisms of CNS damage.Prog Neurobiol2011https://conductscience.org/library/papers/21889967PubMed
929257276Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1.Mol Med Rep2018https://conductscience.org/library/papers/29257276PubMed
1032827663Resveratrol inhibits tumor progression by down-regulation of NLRP3 in renal cell carcinoma.J Nutr Biochem2020https://conductscience.org/library/papers/32827663PubMed
1136430976Protein Misfolding and Aggregation in the Brain: Common Pathogenetic Pathways in Neurodegenerative and Mental Disorders.Int J Mol Sci2022https://conductscience.org/library/papers/36430976PubMed
1227566199Effect of alcoholic extract of aerial parts of Rosmarinus officinalis L. on pain, inflammation and apoptosis induced by chronic constriction injury (CCI) model of neuropathic pain in rats.J Ethnopharmacol2016https://conductscience.org/library/papers/27566199PubMed
1326464617Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/26464617PubMed
1422258606Inflammasomes in health and disease.Nature2012https://conductscience.org/library/papers/22258606PubMed
1525687021Anti-inflammatory effect of resveratrol in old mice liver.Exp Gerontol2015https://conductscience.org/library/papers/25687021PubMed
1634303665Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.Eur J Pharmacol2021https://conductscience.org/library/papers/34303665PubMed
1732147075Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial.Complement Ther Med2020https://conductscience.org/library/papers/32147075PubMed
1828989978The therapeutic potential of resveratrol: a review of clinical trials.NPJ Precis Oncol2017https://conductscience.org/library/papers/28989978PubMed
1932751625Innate Immune Response to Tick-Borne Pathogens: Cellular and Molecular Mechanisms Induced in the Hosts.Int J Mol Sci2020https://conductscience.org/library/papers/32751625PubMed
2035492620Editorial: Mechanisms of Inflammation and Fibrosis Interplays in the Digestive Diseases.Front Physiol2022https://conductscience.org/library/papers/35492620PubMed

See all 149 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42890382Resveratrol as an immune checkpoint inhibitor to enhance the efficacy of breast cancer immunotherapy.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42890382PubMed
42885307Resveratrol alleviates osteoarthritis progression by inhibiting NLRP3 inflammasome response via the AMPK/PPARγ signaling pathway.Int J Mol Med2026https://conductscience.org/library/papers/42885307PubMed
42405401Resveratrol and the NLRP3 Inflammasome: Unlocking the Anti-inflammatory Potential of a Natural Compound.Curr Pharm Des2026https://conductscience.org/library/papers/42405401PubMed
42356251Resveratrol-Enriched Polygonum cuspidatum Extract Enhances Functional Bioactivity Against Non-Small Cell Lung Cancer Through Modulation of Inflammatory Signaling and Mitochondrial Apoptosis.Nutrients2026https://conductscience.org/library/papers/42356251PubMed
41661106Post-TB lung disease: pathogenesis, host-directed therapies, and the C3HeB/FeJ model for pre-clinical advances.Infect Immun2026https://conductscience.org/library/papers/41661106PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40896702

GET https://conductscience.org/api/papers/v1/40896702/references?page=2